Brought to you by 
Genset nets nearly $100mm in largest-ever genomics IPO
13 Jul 1999
Executive Summary
Paris-based genomics company Genset has netted $99.36mm in its IPO of ADRs representing 1.8mm shares at $16 per ADR, including the underwriters' exercise of over-allotment options for an additional 270,000 shares.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genset nets nearly $100mm in largest-ever genomics IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice